The evolution of polymer based nanoparticles as a drug delivery carrier via pharmaceutical
nano/microencapsulation has greatly promoted the development of nano-and micro …

Biodegradable nanoparticles have been used frequently as drug delivery vehicles due to its
grand bioavailability, better encapsulation, control release and less toxic properties. Various …

Recent advancements in biopharmaceutical industry have facilitated the development of
novel bioactive macromolecular therapeutics. One of the challenges towards the clinical use …

Therapeutics are habitually characterized by short plasma half-lives and little affinity for
targeted cells. To overcome these challenges, nanoparticulate systems have entered into …

Nanoparticle-based drug delivery system (DDS) is considered promising for cancer
treatment. Compared with traditional DDS, the nanoparticle-based DDS shows improved …

Polymeric nanoparticles (PNPs) are promising drug carriers in cancer treatment. Size of the
particles has a significant impact on drug loading, in vivo distribution, extravasation …

Nanotechnological advancement has become a key standard for the diagnosis and
treatment of several complex disorders such as cancer by utilizing the enhanced …

Background Nanoparticles fabricated from the biodegradable and biocompatible polymer,
polylactic-co-glycolic acid (PLGA), are the most intensively investigated polymers for drug …

The functionality of bare polylactide-co-glycolide (PLGA) nanoparticles is limited to drug
depot or drug solubilization in their hard cores. They have inherent weaknesses as a drug …

Docetaxel is a highly potent anticancer agent being used in a wide spectrum of cancer
types. There are important matters of concern regarding the drug's pharmacokinetics related …